Skip to content
gov.uk· MHRA (UK)·· 1 day agoPickScore51

MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicines

MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicines

In brief

The Medicines and Healthcare products Regulatory Agency (MHRA) has set out plans to modernise patient-centred regulation in preparation for an era of AI and personalised medicines. The strategy, running to 2030, aims to translate scientific and technological innovation into better health outcomes for patients across all four nations of the UK. Implementation of the strategy's measures is the next step for the agency.

Why it matters

MHRA's 2030 strategy will shape how AI and personalised medicines are regulated in the UK.

Source: gov.uk · gov.uk

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org